查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1747898

全球放射性示踪剂市场

Radioactive Tracers
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 249 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球放射性示踪剂市场规模将达到 56 亿美元

全球放射性示踪剂市场规模预计在2024年达到37亿美元，预计2024年至2030年期间的复合年增长率为7.0%，到2030年将达到56亿美元。诊断用放射性示踪剂是本报告分析的细分市场之一，预计其复合年增长率为8.0%，到分析期结束时市场规模将达到37亿美元。治疗用放射性示踪剂细分市场在分析期间内的复合年增长率预计为4.8%。

美国市场规模估计为 9.848 亿美元；中国市场预期复合年增长率为 6.7%

美国放射性示踪剂市场规模预计2024年达到9.848亿美元。预计到2030年，作为世界第二大经济体的中国市场规模将达到8.978亿美元，在2024-2030年的分析期内，复合年增长率为6.7%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.6%和5.8%。在欧洲，预计德国市场的复合年增长率为5.5%。

全球「放射性示踪剂」市场—主要趋势与驱动因素摘要

放射性示踪剂是否是支持精准诊断和工业发现的无名英雄？

放射性示踪剂已从一种小众的科学工具转变为医疗和工业领域不可或缺的资产。在医疗保健领域，这些同位素化合物在核子医学中至关重要，它们用于透过PET（正子断层扫描）和SPECT（单光子发射电脑断层扫描）等成像方式即时可视化生理过程。这种能力可以早期发现癌症、心血管疾病和神经系统疾病等疾病，显着改善治疗效果。除了医疗保健之外，放射性示踪剂在工业应用中也发挥着至关重要的作用，例如管道洩漏检测、地下水流测绘以及复杂製造过程中的化学反应监测。它们能够以极高的精度追踪微量物质，这使得它们在对精度要求极高的环境中备受重视。监管机构和学术机构持续扩大对半衰期更短、安全性更高的新型同位素的研究，以实现更广泛的应用。放射性示踪剂以其微创性和极强的洞察力，彻底改变了生物和物理科学中资料收集的方式，并牢固地巩固了其在现代创新中的价值。

为什么同位素生产的进步会改变示踪剂的模式？

同位素生产技术的进步显着改善了围绕放射性示踪剂的整个生态系统。传统上依赖核子反应炉的示踪同位素生产正日益得到高功率迴旋加速器和直线加速器的补充。这些设施可以根据需要在局部生产广泛用于 PET 和 SPECT 诊断的同位素，例如氟-18、Technetium-99m 和镓-68。同位素生产的分散化减少了对国际核子反应炉设施的依赖，最大限度地减少了运输过程中的物流瓶颈和同位素崩坏。此外，新的放射化学技术提高了示踪剂的产量、纯度和稳定性，并增强了影像性能和病患安全性。放射性药物合成的自动化使医院和影像中心能够内部配製剂量，缩短了治疗时间，并可以根据特定的临床需求定製配方。在工业环境中，放射性同位素示踪材料经过精心设计，在恶劣环境下具有更高的耐用性和精度。这些突破不仅优化了现有的应用，也将示踪剂的使用扩展到个人化医疗、农业化学品研究、先进材料分析等新领域。随着生产技术的日益成熟，示踪剂使用的可及性、效率和创新性正在提升到新的高度。

不断扩大的临床和工业应用能否维持长期的市场发展动能？

放射性示踪剂的应用比以往任何时候都更加多样化，这对于维持长期的市场发展动能至关重要。在临床应用中，镏不仅对诊断至关重要，而且对治疗诊断应用也至关重要，治疗诊断是指使用同一种放射性标记物将影像诊断与标靶治疗相结合。例如，镏-177因其同时具有诊断潜力而在前列腺癌和神经内分泌肿瘤的治疗中备受关注。在心臟病学领域，铷-82等示踪剂可以增强心肌灌注的即时评估。在工业领域，示踪剂越来越多地用于环境监测，以研究土壤侵蚀、沉积物输送和污染物扩散。在石油和天然气领域，示踪剂被用于储存表征和提高采收率过程。此外，食品和农业研究人员正在利用示踪剂评估作物的养分吸收并监测农药的吸收。示踪剂在药物开发中的效用，尤其是在药物动力学和生物分布研究中，是另一个快速发展的领域。随着各领域对精度的要求日益提高，放射性同位素固有的可追溯性使其成为无与伦比的工具。终端用途的扩展不仅创造了持续的需求，也刺激了多学科创新，而示踪技术在其中发挥核心作用。

是什么推动了放射性示踪剂市场的持续成长？

放射性示踪剂市场的成长受到多种因素的驱动，这些因素与技术进步、终端应用的拓展以及业务效率的提高有关。从技术角度来看，同位素合成、微型迴旋加速器开发以及自动化放射性标记系统的创新显着提高了示踪剂的可得性、一致性和安全性。在医疗保健领域，慢性疾病（尤其是癌症和心血管疾病）的发生率不断上升，推动了对放射性追踪剂独特提供的早期诊断工具的需求。示踪剂与PET/CT和PET/MRI等混合影像系统的集成，进一步推动了其在精准医疗中的应用。在工业领域，对永续实践和高效资源管理的追求，使得示踪剂在流量分析、洩漏检测和製程优化方面发挥了重要作用。政府和私人机构对核子医学的资金投入不断增加，以及对放射性药物研发的投资不断增加，正在推动商业规模的技术创新。消费行为趋势也在发挥作用，因为日益增强的健康意识正在推动非侵入性诊断程序的采用。此外，监管机构的支持，例如加速核准和全球安全标准的协调，也使新型示踪剂製剂能够顺利进入市场。这些市场驱动因素共同推动了全球放射性示踪剂市场在临床和工业领域的强劲扩张。

部分

类型（诊断放射性追踪剂、治疗放射性追踪剂、其他类型）、应用（肿瘤学、心臟病学、神经病学、甲状腺、整形外科、内分泌学、其他应用）、最终用户（医院、专科诊所、诊断中心、学术和研究机构、其他最终用户）

受访公司范例（总合48家公司）

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion（Canada）Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口（成品和原始OEM）来预测其竞争地位的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括人为提高销货成本、盈利下降、供应链重组以及其他微观和宏观市场动态。

全球产业分析师密切关注来自全球顶尖首席经济学家（14,949位）、智库（62家）以及贸易和产业协会（171家）的专家的意见，以评估其对生态系统的影响并应对新的市场现实。我们追踪了来自每个主要国家的专家和经济学家对关税及其对本国影响的看法。

全球产业分析师预计，这场动盪将在未来2-3个月内逐渐平息，新的世界秩序将更加清晰地建立。全球产业分析师正在即时追踪这些事态发展。

2025年4月：谈判阶段

在4月的报告中，我们将探讨关税对全球整体市场的影响，并提供区域市场调整。我们的预测是基于历史数据和不断变化的市场影响因素。

2025年7月：最终关税调整

在各国宣布最终重置后，客户将在 7 月收到免费更新，最终更新将包含明确的关税影响分析。

相互和双边贸易及关税影响分析：

美国<>中国<>墨西哥<>加拿大<>欧盟<>日本<>印度<>其他176个国家

领先的产业经济学家：全球产业分析师知识库追踪了 14,949 位经济学家，其中包括来自民族国家、智库、贸易和产业协会、大型企业以及各领域专家的最具影响力的首席经济学家，他们共用了这场前所未有的全球经济状况模式转移的影响。我们超过 16,491 份报告大多遵循基于里程碑的两阶段发布计划。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP35635

Global Radioactive Tracers Market to Reach US$5.6 Billion by 2030

The global market for Radioactive Tracers estimated at US$3.7 Billion in the year 2024, is expected to reach US$5.6 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Diagnostic Radioactive Tracers, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$3.7 Billion by the end of the analysis period. Growth in the Therapeutic Radioactive Tracers segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$984.8 Million While China is Forecast to Grow at 6.7% CAGR

The Radioactive Tracers market in the U.S. is estimated at US$984.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$897.8 Million by the year 2030 trailing a CAGR of 6.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.6% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.5% CAGR.

Global "Radioactive Tracers" Market - Key Trends & Drivers Summarized

Are Radioactive Tracers The Invisible Heroes Powering Precision Diagnostics And Industrial Discovery?

Radioactive tracers have transformed from a niche scientific tool to an indispensable asset across both the medical and industrial sectors. In healthcare, these isotopic compounds are pivotal in nuclear medicine, where they are used to visualize physiological processes in real time through imaging modalities like PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). This capability enables early detection of diseases such as cancer, cardiovascular disorders, and neurological conditions, improving treatment outcomes significantly. Beyond medicine, radioactive tracers play a critical role in industrial applications like leak detection in pipelines, mapping underground water flows, and monitoring chemical reactions in complex manufacturing processes. Their ability to track minute quantities of substances with exceptional accuracy makes them invaluable in environments where precision is non-negotiable. Regulatory agencies and academic institutions continue to expand research into newer isotopes with lower half-lives and improved safety profiles, making them more viable for broader applications. With minimal invasiveness and maximum insight, radioactive tracers are revolutionizing how data is gathered in the biological and physical sciences alike, anchoring their value firmly in modern innovation.

Why Are Advancements In Isotope Production Reshaping The Tracer Landscape?

The entire ecosystem surrounding radioactive tracers has been significantly elevated by advancements in isotope production technologies. Traditionally reliant on nuclear reactors, tracer isotope production is increasingly being supplemented by high-output cyclotrons and linear accelerators. These facilities allow for localized, on-demand generation of isotopes such as fluorine-18, technetium-99m, and gallium-68, which are widely used in PET and SPECT diagnostics. The decentralization of isotope production has reduced dependency on international reactor facilities, minimizing logistical bottlenecks and isotope decay during transit. Additionally, new radiochemistry techniques have improved the yield, purity, and stability of tracers, enhancing both their imaging performance and patient safety. Automation in radiopharmaceutical synthesis is allowing hospitals and imaging centers to prepare doses in-house, reducing time to treatment and customizing formulations based on specific clinical needs. In industrial settings, radioisotope tracing materials are being engineered for greater durability and precision in harsh environments. These breakthroughs are not only optimizing current applications but also expanding tracer use into emerging areas such as personalized medicine, agrochemical research, and advanced material analysis. As production technologies grow more sophisticated, accessibility, efficiency, and innovation in tracer use are scaling to new heights.

Can Expanding Clinical And Industrial Applications Sustain Long-Term Market Momentum?

Radioactive tracers are experiencing unprecedented diversification in their applications, which is instrumental in sustaining long-term market momentum. In clinical environments, they are now integral not only for diagnosis but also for theranostic applications-where diagnostic imaging and targeted therapy converge using the same radiolabeled agent. For instance, lutetium-177 is gaining ground in treating prostate cancer and neuroendocrine tumors with simultaneous diagnostic capability. In cardiology, tracers like rubidium-82 are enhancing real-time assessment of myocardial perfusion. Industrially, tracers are increasingly being utilized in environmental monitoring to study soil erosion, sediment transport, and pollutant dispersion. The oil and gas sector uses them for reservoir characterization and enhanced recovery processes. Moreover, food and agriculture researchers deploy radioactive tracers to evaluate nutrient uptake in crops and monitor pesticide absorption. The utility of tracers in drug development-especially in pharmacokinetics and biodistribution studies-is another burgeoning area. As precision requirements rise across disciplines, the inherently traceable nature of radioisotopes positions them as unmatched tools. This expansion of end-uses is not only generating consistent demand but also fostering interdisciplinary innovation where tracer technology plays a central role.

What’s Fueling The Relentless Growth In The Radioactive Tracers Market?

The growth in the radioactive tracers market is driven by several factors related to technological evolution, end-use expansion, and operational efficiency. Technologically, innovations in isotope synthesis, miniaturized cyclotron development, and automated radiolabeling systems have significantly enhanced tracer availability, consistency, and safety. In healthcare, the rising incidence of chronic diseases-particularly cancer and cardiovascular disorders-has escalated demand for early diagnostic tools that radioactive tracers uniquely provide. The integration of tracers into hybrid imaging systems like PET/CT and PET/MRI is further boosting their adoption in precision medicine. In industrial domains, the push for sustainable practices and efficient resource management has made tracers invaluable in flow analysis, leak detection, and process optimization. Increased funding in nuclear medicine by governments and private institutions, along with growing investments in radiopharmaceutical R&D, are propelling commercial-scale innovation. Consumer behavior trends also play a part, as rising health awareness encourages uptake of non-invasive diagnostic procedures. Additionally, regulatory support in terms of expedited approvals and global harmonization of safety standards is enabling smoother market entry for new tracer formulations. Collectively, these drivers are shaping a robust and expanding global market for radioactive tracers across both clinical and industrial verticals.

SCOPE OF STUDY:

The report analyzes the Radioactive Tracers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers, Other Types); Application (Oncology, Cardiology, Neurology, Thyroid, Orthopedic, Endocrinology, Other Applications); End-User (Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes, Other End-Users)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

  • ABX Advanced Biochemical Compounds
  • Advanced Accelerator Applications
  • Bayer AG
  • Blue Earth Diagnostics
  • Bracco Imaging
  • Cardinal Health
  • Curium
  • DuChemBio Co., Ltd.
  • Eckert & Ziegler
  • GE HealthCare
  • IBA Radiopharma Solutions
  • Invicro LLC
  • Jubilant Radiopharma
  • Lantheus Holdings, Inc.
  • Mallinckrodt Nuclear Medicine LLC
  • Nordion (Canada) Inc.
  • NorthStar Medical Radioisotopes LLC
  • NTP Radioisotopes
  • Siemens Healthineers
  • Telix Pharmaceuticals Limited

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Radioactive Tracers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer and Chronic Diseases Drives Clinical Adoption of Radioactive Tracers
    • Technological Advances in PET and SPECT Imaging Strengthen Demand for Precision Tracers
    • Expansion of Nuclear Medicine Infrastructure Globally Sustains Supply and Demand Growth
    • Government Support for Diagnostic Imaging and Radiopharmaceutical R&D Spurs Innovation
    • Growing Use of Tracers in Personalized Medicine and Targeted Therapy Expands Clinical Relevance
    • Aging Population and Early Diagnosis Trends Accelerate Use of Diagnostic Tracers
    • Supply Chain Constraints and Short Half-Life of Isotopes Present Logistical Challenges
    • Partnerships Between Hospitals and Radiopharmacies Strengthen Distribution Models
    • Rising Research in Neurology and Cardiology Imaging Drives Diversification of Tracer Applications
    • Increasing Regulatory Approvals for Novel Tracers Expand the Therapeutic Toolbox
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Radioactive Tracers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Diagnostic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Diagnostic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Therapeutic Radioactive Tracers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Therapeutic Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Thyroid by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Thyroid by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Orthopedic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Orthopedic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Endocrinology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Endocrinology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Specialty Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Specialty Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other End-Users by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other End-Users by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • JAPAN
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • CHINA
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • EUROPE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Radioactive Tracers by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Radioactive Tracers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • FRANCE
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • GERMANY
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Europe 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Europe 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Radioactive Tracers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Asia-Pacific 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Radioactive Tracers by Type - Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of World 15-Year Perspective for Radioactive Tracers by Type - Percentage Breakdown of Value Sales for Diagnostic Radioactive Tracers, Therapeutic Radioactive Tracers and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Radioactive Tracers by Application - Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of World 15-Year Perspective for Radioactive Tracers by Application - Percentage Breakdown of Value Sales for Other Applications, Oncology, Cardiology, Neurology, Thyroid, Orthopedic and Endocrinology for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of World Recent Past, Current & Future Analysis for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of World Historic Review for Radioactive Tracers by End-user - Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of World 15-Year Perspective for Radioactive Tracers by End-user - Percentage Breakdown of Value Sales for Hospitals, Specialty Clinics, Diagnostic Centers, Academic & Research Institutes and Other End-Users for the Years 2015, 2025 & 2030

IV. COMPETITION